title: Comment on "CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy".
abstract: Scientists from the maker of the Pandemrix vaccine for influenza present their views on results linking epitopes in influenza and narcolepsy.
authors: GlaxoSmithKline Vaccines, Rixensart, Rixensart 3090, Belgium. robbert.x.van-der-most@gsk.com.
authors: Robbert
authors: R
authors: van der Most
authors: GlaxoSmithKline Vaccines, Rixensart, Rixensart 3090, Belgium.
authors: Martine
authors: M
authors: Wettendorff
authors: GlaxoSmithKline Vaccines, King of Prussia, PA 19406, USA.
authors: Bruce
authors: B
authors: Innis
authors: GlaxoSmithKline Vaccines, Rixensart, Rixensart 3090, Belgium.
authors: Emmanuel
authors: E
authors: Hanon
mesh_terms: D015551:Autoimmunity; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000276:immunology*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D047908:Intracellular Signaling Peptides and Proteins / Q000276:immunology*; D008297:Male; D009290:Narcolepsy / Q000276:immunology*; D009479:Neuropeptides / Q000276:immunology*
chemical_list: D019267:Hemagglutinin Glycoproteins, Influenza Virus; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides